11 Papers
19 Citations
Lan He is an academic researcher from Southern Medical University. The author has contributed to research in topics: Medicine & Hematopoietic stem cell transplantation. The author has an hindex of 3, co-authored 3 publications. Previous affiliations of Lan He include Children's Institute Inc..
Chat about Author
Papers
A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation
Chunfu Li,Xuedong Wu,Xiao-qing Feng,Yuelin He,Huaying Liu,Fuyu Pei,Jianyu Liao,Lan He,Lei Shi,Na Li,Qiujun Liu,Shiting Liu,Geyu Chen,Qingxia Su,Yuqiong Ren,Yanhua Wang,Wanxia Tan +16 more
TL;DR: UD-PBSCTs using the well-tolerated NF-08-TM protocol show similar results to MSD-HSCTs and can be used to treat β-thalassemia patients in the absence of MSDs.
98
Prophylactic First-Line Antibiotics Reduce Infectious Fever and Shorten Hospital Stay during Chemotherapy-Induced Agranulocytosis in Childhood Acute Myeloid Leukemia
Xiaoqin Feng,Yongsheng Ruan,Yue-lin He,Yuming Zhang,Xuedong Wu,Huayin Liu,Xuan Liu,Lan He,Chun-fu Li +8 more
TL;DR: In children with AML, prophylactic antibiotics during the period of chemotherapy-induced agranulocytosis can effectively reduce the incidence of infectious fever and can shorten the average length of hospital stay, improving treatment success and quality of life.
19
Long-term results of the NF-08-TM protocol in stem cell transplant for patients with thalassemia major: A multi-center large-sample study.
Yuelin He,Hua Jiang,Changgang Li,Yiping Zhu,Xuedong Wu,Sixi Liu,Yuhua Qu,Jianyun Liao,Jianyun Liao,Xiaoqin Feng,Huaying Liu,Huaying Liu,Zhiyong Peng,Zhiyong Peng,Lan He,Lan He,Chaoke Pu,Chaoke Pu,Mandeep Gautam,Wing Leung,Chunfu Li,Chunfu Li +21 more
TL;DR: Among the 486 HSCTs with the median follow-up time of 56 months, overall survival (OS), thalassemiafree survival (TFS), graft rejection (GR) and transplant related mortality (TRM) were 94.7%, 93.3%, 2.8% and 5.3% (Figure 1), respectively.
10
Reversal of SLE and hemophagocytic lymphohistiocytosis caused by lysinuric protein intolerance through allogeneic hematopoietic stem cell transplantation.
TL;DR: Tangye et al. as mentioned in this paper presented the case of a patient with LPI as well as SLE, PAP, and HLH, and for the first time, they demonstrate the successful use of allogeneic hemopoietic stem cell transplantation (HSCT) to reverse the progression of immunologic disorders caused by LPI.
4
Double Donor Lymphocytes Infusion Reduced the Rejection in Tαβ Cell Depleted Hematopoietic Stem Cell Transplantation from Haploidentical Donors for Thalassemia Patients
Jianyu Liao,Chaoke Bu,Lan He,Yuelin He,Jujian He,Dan Chen,Bo Lyu,Weiwei Zhang,Haoran Tang,Xinrui Liu,Chunfu Li +10 more
TL;DR: Wang et al. as mentioned in this paper showed that double donor lymphocyte infusion (DLI) reduced the rejection in haplo-TDH for thalassemia major (TM) patients.
1